Compare PPCB & CYAB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
| Metric | PPCB | CYAB |
|---|---|---|
| Founded | 2007 | 2017 |
| Country | Australia | Israel |
| Employees | N/A | N/A |
| Industry | | |
| Sector | | |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.6M | 2.6M |
| IPO Year | 2011 | 2026 |
| Metric | PPCB | CYAB |
|---|---|---|
| Price | $0.32 | $0.15 |
| Analyst Decision | | Buy |
| Analyst Count | 0 | 2 |
| Target Price | N/A | ★ $1.00 |
| AVG Volume (30 Days) | 213.1K | ★ 2.3M |
| Earning Date | 11-16-2026 | 11-18-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | N/A | ★ N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | $42.03 |
| Revenue Next Year | N/A | $77.74 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $0.06 | $0.14 |
| 52 Week High | $6.79 | $3.98 |
| Indicator | PPCB | CYAB |
|---|---|---|
| Relative Strength Index (RSI) | 25.33 | 31.82 |
| Support Level | $0.17 | N/A |
| Resistance Level | $0.40 | $0.35 |
| Average True Range (ATR) | 0.05 | 0.02 |
| MACD | 0.00 | -0.00 |
| Stochastic Oscillator | 2.01 | 17.76 |
Propanc Biopharma Inc is a development-stage healthcare company. It focuses on developing new cancer treatments for patients suffering from pancreatic, ovarian, and colorectal cancer. The company develops a rational, composite formulation of the anti-cancer compound, which together exert a number of effects designed to control or prevent tumors from recurring and spreading through the body. Its product, PRP, is a variation upon its novel formulation and involves proenzymes, the inactive precursors of enzymes.
Cyabra Inc is an AI-powered SaaS company that detects and analyzes online disinformation. Its platform uses machine learning to monitor social media and news data in real time, identify fake accounts and harmful narratives, and assess content authenticity and sentiment.